hospitalisation and ICU beds have remained low since early March 22 after a peak in Dec 21 Q.
just google it, data is there.
anyway as you say US is profitable, so it’s a matter of boosting that to cover for the rest of the business.
Europe is still in its infancy, and the Indian market may well be entered this year. More costs for the US to cover in FY23. Another long tail wait for sales to outstrip growth. But hopefully by then Europe comes through and starts delivering.
it’s all very exciting and the opportunity to top up at lower prices while this all takes place and while doubt still exists is an opportunity I intend on taking advantage of.
Ann: FY22 Results Presentation, page-327
-
- There are more pages in this discussion • 169 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.59 |
Change
0.220(9.28%) |
Mkt cap ! $1.787B | |||
| Open | High | Low | Value | Volume |
| $2.44 | $2.62 | $2.44 | $11.81M | 4.632M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 8020 | $2.58 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.59 | 48292 | 7 |
View Market Depth
| Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
| PNV (ASX) Chart |